3 studies found for:    15613699 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NPI-0052
2 Terminated A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Bortezomib
3 Unknown  Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: Velcade + ACVBP regimen

Indicates status has not been verified in more than two years